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Bordetella species utilize the BvgAS (Bordetella virulence gene) two-component signal transduction system to
sense the environment and regulate gene expression among at least three phases: a virulent Bvg phase, a
nonvirulent Bvg phase, and an intermediate Bvgi phase. Genes expressed in the Bvg phase encode known
virulence factors, including adhesins such as filamentous hemagglutinin (FHA) and fimbriae, as well as toxins
such as the bifunctional adenylate cyclase/hemolysin (ACY). Previous studies showed that in the Bvgi phase,
FHA and fimbriae continue to be expressed, but ACY expression is significantly downregulated. In this report,
we determine that Bordetella bronchiseptica can form biofilms in vitro and that the generation of biofilm is
maximal in the Bvgi phase. We show that FHA is required for maximal biofilm formation and that fimbriae may
also contribute to this phenotype. However, expression of ACY inhibits biofilm formation, most likely via
interactions with FHA. Therefore, the coordinated regulation of adhesins and ACY expression leads to
maximal biofilm formation in the Bvgi phase in B. bronchiseptica.
Bordetella pertussis, Bordetella parapertussis, and Bordetella
bronchiseptica are closely related gram-negative coccobacilli
that colonize the upper respiratory tract of mammals. B. per-
tussis and most B. parapertussis strains are obligate human
pathogens that usually cause acute respiratory diseases. B.
bronchiseptica has a much broader host range and is consid-
ered to be representative of the evolutionary progenitor of all
Bordetella spp. (10, 27). It naturally infects many laboratory
animals, including mice, rats, and rabbits, and thus serves as an
ideal model for studying bacterial pathogenesis in a natural
infection setting. Although B. bronchiseptica has been associ-
ated with various respiratory diseases, infection by this organ-
ism generally leads to chronic and asymptomatic colonization
in the host. This lifestyle indicates that the bacteria employ
specific mechanisms to counteract host immune responses and
also implies successful interactions with other commensal bac-
teria commonly found in the upper respiratory tract.
Most known virulence factors in Bordetella are regulated by
the BvgAS (Bordetella virulence gene) two-component signal
transduction system (21). In response to environmental stim-
uli, BvgAS undergoes a series of phosphorelay signal transduc-
tion events that ultimately lead to differential transcriptions of
target genes (6). Bacteria grown in rich media at 37°C exhibit
the virulent Bvg phase, and this phase is characterized by the
expression of virulence factors, such as filamentous hemagglu-
tinin (FHA), fimbriae, and bifunctional adenylate cyclase/he-
molysin (ACY). Specific genes, such as those required for
motility (2), are repressed in the Bvg phase but are expressed
when the bacteria are grown in Bvg-phase conditions. The
BvgAS system is not a simple on/off switch, as a distinct inter-
mediate Bvgi phase can be achieved with growth of the bacteria
in phase-modulating conditions that are between that of the
extreme Bvg and Bvg phases. The Bvgi phase is character-
ized by expression of specific genes, e.g., bipA (30), that are
highly expressed only in the Bvgi phase but not in the Bvg or
Bvg phases. However, some genes are highly expressed in
both the Bvg and Bvgi phases (e.g., those encoding FHA and
fimbriae), whereas others are expressed in the Bvg but not
the Bvgi phase (e.g., ACY) (8). Although the actual environ-
mental signal(s) sensed by BvgAS during infection has not yet
been identified, certain laboratory growth conditions can be
used to modulate the Bordetella expression profile to the Bvg
phase: growth at room temperature (25°C) or in the presence
of millimolar concentrations of nicotinic acid or MgSO4 (16).
A semimodulating concentration of nicotinic acid concentra-
tion between 0.2 and 1.6 mM nicotinic acid in the growth
medium leads to the Bvgi-phase phenotype (8). Furthermore,
there are specific mutants of the BvgAS system that perma-
nently lock the bacteria in each of the three phases, and they
are insensitive to environmental modulations (7, 8).
FHA and fimbriae are two major adhesins that have been
studied in Bordetella spp. FHA displays multiple attachment
activities (20) and has been demonstrated to be important for
adhesion of Bordetella spp. to cell surfaces (30) and also for the
colonization of the trachea in animal models (9). Bordetella
fimbriae has also been demonstrated to function as an adhesin
in vitro and in vivo (22, 23). While both FHA and fimbriae are
generally considered Bvg-phase factors, they remain highly
expressed in the Bvgi phase as well (6).
ACY is a bifunctional protein displaying both the adenylate
cyclase and hemolytic activities. It can be translocated into
infected host cells where it catalyzes the production of intra-
cellular cyclic AMP, resulting in the suppression of various
host cell functions (17). It also plays an important role in the
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interaction of the bacteria with neutrophils in vivo (11). How-
ever, ACY has also been shown to be associated with the cell
surface of Bordetella and can bind specifically to FHA in vitro
(36). ACY is highly expressed in the Bvg phase but is signif-
icantly downregulated in the Bvgi phase (8).
Biofilms are bacterial communities that adopt a surface-
adapted, adherent multicellular lifestyle that appears to be
fundamentally different from the free-living planktonic state
(24, 33, 34). Biofilm communities may be the predominant
lifestyle of most bacteria in nature and may also be that of
bacteria that have adapted to adherent lifestyles on various
artificial structures. The role of biofilms in the pathogenesis of
various bacterial infections may be particularly important, as
many chronic infections, such as cystic fibrosis airway infec-
tions by Pseudomonas aeruginosa, endocarditis, and periodon-
titis, are strongly associated with biofilm formation (5, 28).
Regulation of biofilm formation in various bacterial species
has been shown to be dependent on the expression of various
cell surface structures and proteins (24). Furthermore, specific
signaling pathways and cell-cell communication mechanisms
are also important to the establishment of many well-studied
biofilms and the dynamic equilibrium that is thought to exist
between planktonic bacterial cells and biofilms (13).
In this report, we show that B. bronchiseptica can form bio-
films in vitro and that the BvgAS system regulates this pheno-
type. We show that FHA and fimbriae contribute to the for-
mation of biofilm, but ACY inhibits the generation of biofilm.
We propose that the differential regulation of FHA, fimbriae,
and ACY in various Bvg phases, coupled with the interaction
between FHA and ACY, give rise to a strong biofilm pheno-
type in the Bvgi phase.
MATERIALS AND METHODS
Bacterial strains and growth conditions. B. bronchiseptica strains RB50 (wild
type), RB53i (Bvgi phase-locked, bvgS R570H, T733M), RB58 (cyaA, deleted of
all but 61 codons at the 5 end and 65 codons at the 3 end, resulting in 97.5%
of the gene deleted), RBX9 (fhaB, deleted of all but four codons at the 5 end
and five codons at the 3 end), and RB63 (fimBCD, deleted from codon 72 of
fimB to codon 327 of fimD of the fimBCD locus) were previously reported and
well characterized (7–9, 11, 22). All of these mutants were in-frame deletions. A
double in-frame deletion mutant in both fhaB and cyaA was constructed by an
allelic exchange strategy as described previously (1), using the same vectors that
were used for construction of RBX9 and RB58. All strains were cultured in
Stainer-Scholte (SS) liquid medium (29) or on BG agar (Becton Dickinson)
supplemented with defibrinated sheep blood at 37°C. For Bvg phase modulation,
bacteria were grown in SS media with nicotinic acid (Sigma) added to appropri-
ate final concentrations.
Microscopy. Glass coverslips with attached biofilm from overnight cultures
were stained with Syto Red 17 (a nucleic acid stain; Molecular Probes) for 30
min, which labels both live and dead cells. The coverslips were washed and then
mounted onto microscope slides with antifade reagent (SlowFade Light Antifade
kit; Molecular Probes). A Nikon MICROPHOT FXA epifluorescence micro-
scope was used to observe the specimens. A deconvolution micrograph was taken
with a Leica DM R epifluorescence microscope with deconvolution software
(Improvision Volocity).
Quantitative assay of biofilm. Biofilms were grown in non-tissue-culture-
coated 96-well round-bottom polystyrene plates (Corning) essentially as de-
scribed previously (26). Briefly, overnight cultures were inoculated to 1:20 dilu-
tions (for single-strain biofilms) or 1:40 dilutions per strain (for dual-strain
biofilms) and were added to 100 l of SS/well supplemented with appropriate
concentrations of nicotinic acid. After 24 h of incubation at 37°C, each well was
washed with water and was stained with 150 l of crystal violet solution (Becton
Dickinson). The dye was then removed by thorough washing with water. For
quantification of attached cells, crystal violet was solubilized in 200 l of 33%
acetic acid and the absorbance was measured at 595 nm. All strains were grown
in triplicate for individual experiments, and the values were averaged with stan-
dard deviation of errors shown.
RESULTS
B. bronchiseptica generates a maximal biofilm phenotype in
the Bvgi phase in vitro. We had initially observed that wild-
type B. bronchiseptica grown in Bvgi-phase conditions (e.g., in
0.8 mM nicotinic acid) or a Bvgi-phase-locked strain (RB53i,
bvgS R570H, T733M point mutant; remains in Bvgi phase
regardless of growth conditions) primarily formed thick aggre-
gates and grew adherent to the polystyrene test tubes (Fig. 1)
instead of the predominant suspension liquid cultures of bac-
teria grown in Bvg or Bvg phases. The adherent aggregates
were particularly pronounced at the liquid-air interface region
of the cultures grown in tilted roller drums. We examined this
phenotype by microscopy to determine the presence of micro-
colony formation (a hallmark of biofilm formation) under Bvgi
conditions (Fig. 2). Wild-type bacteria grown in Bvg phase on
glass coverslips formed a thin layer with small aggregates
within the layer (Fig. 2A). Wild-type bacteria grown in Bvgi
phase, however, formed more distinct and larger microcolonies
(Fig. 2B). The three-dimensional architecture of a microcolony
shown in Fig. 2B can be seen in Fig. 2D, which is a deconvo-
luted image of a microcolony at higher magnification. Bacteria
grown in Bvg phase did not attach significantly to the cover-
slip, and the attached bacteria did not show formation of mi-
crocolonies (Fig. 2C). Therefore, B. bronchiseptica appears to
form a relatively weak biofilm at Bvg phase but a strong
biofilm phenotype can be observed in the Bvgi phase.
We quantitatively assayed the biofilm formation in polysty-
rene 96-well plates at various concentrations of nicotinic acid
FIG. 1. Biofilm formation by B. bronchiseptica grown in the Bvgi
phase. Overnight liquid cultures of B. bronchiseptica were grown in the
Bvgi phase (0.8 mM nicotinic acid, left) or Bvg phase (4 mM nicotinic
acid, right) in polystyrene culture tubes in continuous rotation on roller
drums. In the Bvgi phase, a majority of the bacteria were adherent to
the test tube wall, in contrast to bacteria that was grown in Bvg phase
(or Bvg phase; data not shown) in which most bacterial cells re-
mained in the liquid media.











to determine the variation of this phenotype at different Bvg
phases. Figure 3 shows that with increasing nicotinic acid con-
centrations, biofilm formation by wild-type B. bronchiseptica
reached a maximum at 0.8 mM nicotinic acid and decreased
with further increases of nicotinic acid concentration. A Bvgi-
phase-locked mutant showed large amounts of biofilm forma-
tion regardless of nicotinic acid concentration in the growth
medium. These observations confirm that B. bronchiseptica
forms a strong biofilm phenotype primarily in the Bvgi phase.
The absorbance values of crystal violet stains (used for quan-
titation of biofilm formation) was not a simple measure of
bacterial growth, as they did not correlate with the total growth
of the bacteria in these wells (i.e., bacterial growth was not
maximal at 0.8 mM nicotinic acid; data not shown). While Fig.
3 is a representative result of several experiments, the absolute
maximum absorbance values varied between 0.5 and 0.8 in
experiments performed on different days, and the maximum
biofilm phenotype was always observed in the range of nico-
tinic acid concentrations between 0.2 and 0.8 mM.
FIG. 2. Formation of microcolonies by B. bronchiseptica on glass coverslips. Wild-type B. bronchiseptica organisms were grown on glass
coverslips and then were stained with Syto Red 17 and observed under a fluorescent microscope (20 objective and 10 eyepiece). (A) Culture medium
with no nicotinic acid (Bvg phase). (B) Culture medium supplemented with 0.8 mM nicotinic acid (Bvgi phase). (C) Culture medium supplemented with
4 mM nicotinic acid (Bvg phase). Bacteria grown in Bvg phase (A) appear to form small aggregates, whereas microcolonies formed by bacteria grown
in Bvgi phase are large and distinct (B). Bacteria in Bvg phase (C) displayed little adherence to the coverslip with no aggregative properties.
(D) Deconvolution micrograph of a microcolony depicted in panel B displaying the cellular architecture of the microcolony. Bar, 7 m.
FIG. 3. Quantitative assay of biofilm formation by wild-type
(RB50) and Bvgi-phased-locked (RB53i) B. bronchiseptica at different
nicotinic acid concentrations. Bacteria were grown in 96-well polystyrene
plates, and biofilm formation was quantified by absorbance of solubilized
crystal violet stains, as described in Materials and Methods. Biofilm for-
mation in the wild-type bacteria peaked in the Bvgi phase (0.2 to 0.8 mM
nicotinic acid). The Bvgi-phase-locked mutant formed high levels of bio-
film at all nicotinic acid concentrations. Bvg-phase growth condition is 0
to 0.1 mM nicotinic acid, 0.2 to 1.6 mM is Bvgi phase, and 4.0 mM (and
above) is Bvg phase. OD595, optical density at 595 nm.











FHA is required for maximum biofilm formation in B. bron-
chiseptica. Various adhesins have been shown to be important
for the formation of biofilm in other bacterial species (24). We
examined the possible role of two Bvg-regulated adhesins ex-
pressed by Bordetella spp., FHA and fimbriae, in biofilm for-
mation (Fig. 4). In a comparison of biofilm formation by wild-
type B. bronchiseptica and a mutant with an in-frame deletion
in the structural gene encoding FHA (fhaB), the mutant
formed significantly less biofilm in the Bvgi phase (at 0.8 mM
nicotinic acid). However, there was no significant decrease of
biofilm formation in the Bvg phase compared to that of the
wild-type bacteria. On the other hand, a mutant that does not
express fimbriae (fimBCD) was highly attenuated in biofilm
formation in the Bvg phase but did not show significant de-
creases in biofilm formation in the Bvgi phase. These results
suggest that FHA plays a primary role in the formation of the
strong biofilm phenotype in the Bvgi phase. Expression of
fimbriae appears to be required for the weaker biofilm pheno-
type that is observed in the Bvg phase.
ACY inhibits biofilm formation in B. bronchiseptica. It was
previously observed that a mutant B. bronchiseptica strain with
an in-frame deletion of the cyaA gene (which codes for ACY)
demonstrated a liquid culture phenotype of aggregation and
adherence similar to that of a Bvgi-phase-locked mutant, even
when the bacteria were grown in Bvg conditions. This indi-
cates that ACY mutants may demonstrate a strong biofilm
phenotype even in the Bvg phase, in contrast to wild-type
bacteria, which have a maximal biofilm phenotype in the Bvgi
phase. Figure 5 shows that the ACY deletion mutant formed a
strong biofilm phenotype in both the Bvg and Bvgi phase but
not in the Bvg phase. This suggests that ACY suppresses
biofilm formation in B. bronchiseptica. A previous report has
demonstrated a direct protein-protein interaction of ACY with
FHA (36). Because FHA appears to be a major contributor to
biofilm formation in B. bronchiseptica, we propose that ACY
may inhibit biofilm formation via its interaction with FHA.
This result is also consistent with previous observations that
FHA is highly expressed in both Bvg and Bvgi phases and that
ACY is highly expressed in the Bvg but not in the Bvgi phase
(8). We examined the biofilm formation of a double mutant
strain with in-frame deletions in both cyaA and fhaB genes
(Fig. 6). The amounts of biofilm formed by this double mutant
in both Bvg and Bvgi phases were significantly lower than that
of the single ACY mutant but were still higher than that of the
single FHA mutant (Fig. 6). Overall, this observation is con-
sistent with the hypothesis that the inhibition of biofilm for-
mation by ACY is at least partially mediated via its interaction
with FHA. However, because the double mutant forms more
biofilm than the single FHA mutant, ACY may inhibit biofilm
formation via other mechanisms besides its possible interac-
tion with FHA.
ACY is secreted and also expressed on the cell surface by
Bordetella spp. (36). We therefore tested if wild-type bacteria
could complement in trans the inhibitory effect of ACY on
biofilm formation by coculturing wild-type bacteria and ACY
mutants. Wild-type B. bronchiseptica was cocultured with ap-
proximately equal numbers of the ACY mutant, and the over-
FIG. 4. Quantitative assay of biofilm formation in wild-type B.
bronchiseptica (RB50), fhaB mutant, and fimBCD mutant in the
Bvg phase (0 mM nicotinic acid) and Bvgi phase (0.8 mM nicotinic
acid). Bacteria were grown in 96-well polystyrene plates, and biofilm
formation was quantified by absorbance of solubilized crystal violet
stains, as described in Materials and Methods. The amount of biofilm
formed by the fhaB mutant in the Bvg phase was similar to that of
the wild-type but was significantly decreased in the Bvgi phase. The
fimBCD mutant appears to form almost no biofilm in the Bvg phase,
but the amount of biofilm formed by this mutant in the Bvgi phase was
comparable to that of the wild-type bacteria. OD595, optical density at
595 nm.
FIG. 5. Quantitative assay of biofilm formation by wild-type B.
bronchiseptica (RB50) and cyaA mutant at different nicotinic acid
concentrations. Bacteria were grown in 96-well polystyrene plates, and
biofilm formation was quantified by absorbance of solubilized crystal
violet stains, as described in Materials and Methods. The cyaA mu-
tant formed high levels of biofilm in both Bvg and Bvgi phases
compared to that of wild-type bacteria, which formed high levels of
biofilm only in the Bvgi phase. OD595, optical density at 595 nm.
FIG. 6. Comparative quantitative assay of biofilm formation by the
cyaA mutant, fhaB mutant, and fhaBcyaA double mutant in the
Bvg phase (0 mM nicotinic acid) and Bvgi phase (0.8 mM nicotinic
acid). Bacteria were grown in 96-well polystyrene plates, and biofilm
formation was quantified by absorbance of solubilized crystal violet
stains, as described in Materials and Methods. The double mutant
formed higher levels of biofilm than the fhaB mutant but formed
lower levels than the cyaA mutant. OD595, optical density at 595 nm.











all level of biofilm formation was quantitatively assayed (Fig.
7). The coculture experiments showed that wild-type bacteria
(which produce and secrete ACY mainly in the Bvg phase)
were able to significantly reduce the level of total biofilm for-
mation when cocultured with the ACY mutant in the Bvg
phase. Moreover, this inhibition was not observed in cocultures
in the Bvgi phase, when ACY expression by the wild-type
bacteria is significantly decreased. In both conditions, both
strains grow at similar rates in the cocultures (data not shown).
This result further supports the idea that the strong biofilm
phenotype observed in the ACY mutant is due to the absence
of the inhibitory effect of ACY on biofilm formation.
DISCUSSION
There is consensus that most bacterial species that thrive on
solid surface environments grow in biofilms, and the number of
species that have been characterized to form biofilms in vitro
continues to increase. In this report, we show that B. bronchi-
septica can form biofilms in vitro. We discovered that the
biofilm phenotype is regulated by the BvgAS two-component
signal transduction system. The BvgAS system regulates a ma-
jority of known virulence factors in Bordetella spp., and our
results suggest that biofilm formation may play an important
role during colonization and pathogenesis within the animal
host. We determine that B. bronchiseptica forms the strongest
biofilm phenotype in vitro in the Bvgi phase. This is demon-
strated by the formation of a strong biofilm phenotype by
wild-type bacteria primarily in Bvgi-phase growth conditions
and also by the consistently high biofilm levels formed by a
Bvgi-phase-locked mutant regardless of growth conditions. We
show that the molecular mechanism for the BvgAS-dependent
biofilm formation at least involves FHA, fimbriae, and ACY
(all of which are regulated by BvgAS). FHA and fimbriae
positively contribute to biofilm formation, while ACY inhibits
biofilm formation, most likely by interacting with FHA.
Various adhesin molecules in other bacteria, pathogenic and
nonpathogenic, have been reported to be important for biofilm
formation (24). In Bordetella spp., FHA and fimbriae have
previously been shown to be important for adhesion to host
cells and, as a consequence, are known to be virulence factors
important in their roles for host colonization and pathogenesis
(9, 22, 30–32). It is therefore not surprising that both FHA and
fimbriae also mediate biofilm formation, probably by promot-
ing attachment to surfaces.
The finding that ACY mutants formed strong biofilms in the
Bvg phase as well as the Bvgi phase led us to propose that
ACY inhibits biofilm formation when it is expressed in the
Bvg phase in wild-type Bordetella spp. Zaretzky et al. re-
ported that ACY and FHA interact with each other by direct
protein-protein binding on the outer membrane surface of B.
pertussis (36). We suggest that this interaction also occurs in B.
bronchiseptica and is at least partly responsible for the inhibi-
tion of biofilm formation by ACY. Indeed, in the double mu-
tant strain that does not express both FHA and ACY, the
amount of biofilm formed in both Bvg and Bvgi phases is
significantly less than that observed in the single ACY mutant.
This suggests that at least part of the mechanism of inhibition
of biofilm formation by ACY involves its interaction with FHA.
However, the double mutant still forms more biofilm than the
single FHA mutant, suggesting that ACY may interact with
other yet unidentified factors to suppress biofilm formation.
The expression of ACY is limited to Bvg phase, and therefore
the strong Bvgi-phase biofilm trait observed in wild-type B.
bronchiseptica is most likely due to the absence of significant
ACY expression in Bvgi phase. This is also supported by the
observation that cocultures of both wild-type bacteria and
ACY mutants led to a significant reduction in overall biofilm
formation compared to that of ACY mutants alone. The ability
of the wild-type bacteria to trans complement the biofilm in-
hibition phenotype suggests that either ACY secreted into the
medium can interact with FHA in trans or ACY that is present
on the cell surface of wild-type cells can interact with mutant
cells in close proximity to limit overall biofilm formation. The
reduction in biofilm formation in the cocultures is limited to
cultures grown in the Bvg phase but not in the Bvgi phase,
and this is consistent with the reduced expression of ACY in
the Bvgi phase by wild-type bacteria.
The physiological relevance of Bvg-dependent biofilm for-
mation has potential implications in understanding the lifestyle
of B. bronchiseptica as a chronically colonizing pathogen. In the
Bvg phase, B. bronchiseptica does not appear to form biofilms
in vitro. As the Bvg phase is proposed to be important for
survival outside of the host, our results suggest that biofilm
formation may not be critical for this phase of the B. bronchi-
septica life cycle. Both the Bvg and Bvgi phases are likely to
be important for successful interactions of B. bronchiseptica
with the host. The upper nasopharynx, particularly the nasal
mucosa, is one of the primary colonization sites for B. bron-
chiseptica. The temperature in this area in mammals is mea-
sured to be between 30 and 34°C (19). Temperature is an
environmental signal that can mediate Bvg regulation, and this
range of temperature would modulate the bacteria into the
Bvgi phase. Therefore, B. bronchiseptica organisms that colo-
nize this region of the host may be predominantly in the Bvgi
phase and may form biofilms. We cannot, however, exclude the
possibilities that the bacteria are sensing other signals from the
nasal cavity, from the host directly, or from other bacterial
species residing in the area. Bacteria can detach from mature
FIG. 7. Quantitative assay of biofilm formation in cocultures con-
taining both wild-type B. bronchiseptica (RB50) and the cyaA mutant
in the Bvg phase (0 mM nicotinic acid) and Bvgi phase (0.4 mM
nicotinic acid). Bacteria were grown in 96-well polystyrene plates, and
biofilm formation was quantified by absorbance of solubilized crystal
violet stains, as described in Materials and Methods. Coculture of
RB50 with the cyaA mutant results in a low level of biofilm (compa-
rable to that of RB50 alone) in the Bvg phase, but no significant
reduction of biofilm formation in the coculture was observed in the
Bvgi phase. OD595, optical density at 595 nm.











biofilms, and such planktonic cells are presumed to colonize
other sites and form new biofilms (33). It is possible that
detached cells from B. bronchiseptica biofilms in the nasophar-
ynx of infected hosts might also contribute to the process of
transmission to new hosts. Although we do not yet have direct
evidence that B. bronchiseptica actually forms biofilms in vivo
during infections, the fact that this phenotype is Bvg-regulated
strongly indicates that it is involved in bacteria-host interac-
tions.
Biofilms appear to be more resistant to antibiotics and host
immunity than are planktonic cells (12, 18). B. bronchiseptica
infections are characterized by long-term chronic colonization
of the upper respiratory tract, and biofilm formation may be a
primary mechanism for their survival in the host and in suc-
cessful interactions with other bacteria. Tuomanen et al. re-
ported that other bacteria can utilize B. pertussis FHA to attach
to host cells (31), and B. pertussis infection is often associated
with superinfections of other respiratory pathogens. The pos-
sible interactions between various respiratory pathogens, such
as those within multispecies biofilms, may be critical for the
pathogenesis of bacterial respiratory infections. We are pres-
ently investigating the possible influence of other common
respiratory commensal bacteria on biofilm formation by B.
bronchiseptica (and vice versa) in coinfection models in vitro.
The developmental biology of biofilm formation can be
characterized into three stages: the initial attachment, devel-
opment of microcolony formation, and detachment (24). The
initial attachment is often mediated by various adhesins, such
as fimbriae in Salmonella enteritidis (4) and type IV pili in P.
aeruginosa (25). Cell proliferation and type IV pili-driven
twitching motility appear to be important for further micro-
colony formation (14, 15). It is not clear yet at which stages
fimbriae and FHA participate in B. bronchiseptica biofilm for-
mation. In addition, the detachment of bacterial cells from
biofilm microcolonies is not well understood, but the possible
roles of polysaccharide lyase (3) and cell death and survival
within microcolonies (35) have been proposed. We are pres-
ently conducting experiments to understand and characterize
the developmental aspects of B. bronchiseptica biofilm forma-
tion and the molecular mechanisms of these processes.
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